CASI PHARMACEUTICALS, INC. Debt Securities, Available-for-sale
CASI PHARMACEUTICALS, INC. (CASIF) had Debt Securities, Available-for-sale of $12.01 million as of 2023-12-31, per its 20-F filed 2025-03-31.
Financial Statements › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2025-03-31
- 2023-12-31: Debt Securities, Available-for-sale $12.01M.
- 2022-12-31: Debt Securities, Available-for-sale $1.46M.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2023-12-31 | $12.01M 20-F · filed 2025-03-31 |
| 2022-12-31 | $1.46M 20-F · filed 2024-03-28 |